Almac provides services for all stages of drug development for small molecules (including highly potent) and peptides. We have a proven track record of saving time and cost through the integration of our services and application of innovative biocatalysis and technology solutions.
We understand our clients’ needs to process New Chemical Entities (NCEs) through clinical development faster, smarter and cost effectively. From stand-alone to fully integrated services, our highly skilled scientists work closely with clients to ensure high quality, on time and in full delivery of their outsourced projects.
Almac’s strength in API development and manufacture is proven by being the partner of choice for pharma and biotech companies seeking integrated drug development solutions from molecule to market. Our technical expertise and extensive facilities enable us to offer integrated API contract manufacturing solutions through all stages of the drug development lifecycle.
Complementing our API services, Almac supports a world-leading biocatalysis technology platform to secure the supply of biocatalysts for non-GMP and GMP manufacturing projects alike. Expertise ranges from enzyme production to the synthesis of complex APIs and advanced intermediates from mg-tonne scale.
Additionally, we have supplied peptides to the research community and for clinical trials for over 10 years and developed specialised technical expertise which allows us to manufacture peptides with a wide range of complexity in dedicated non-GMP and GMP facilities.
Our core services are supported by specialist departments ensuring the needs of your drug development programme are fully met. These include 14C radiolabelling, preformulation, solid state services and an extensive analytical team.